comparemela.com

Latest Breaking News On - Tyvaso remodulin - Page 1 : comparemela.com

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2023 Earnings Call Transcript

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2023 Earnings Call Transcript February 21, 2024 United Therapeutics Corporation beats earnings expectations. Reported EPS is $4.36, expectations were $3.92. United Therapeutics Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]

Japan
Tyvaso-remodulin
Martine-rothblatt
Michael-benkowitz
Parenteral-prostacyclin
Specialty-pharmacy
Booming-stocks
Buy-right-now
Least-shorted-stocks
United-therapeutics
Martine-rothblatt

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.